Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E1ST
|
|||
| Drug Name |
CAR-T cells targeting GD2
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [1] | |
| Company |
Fuda Cancer Hospital, Guangzhou
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ganglioside GD2 (GD2) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03252171) CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.